About Globomedica
Globomedica is a Healthcare company based in Egg (Switzerland) founded in 2009, and was acquired by The Biomedica in March 2016. Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland. Globomedica offers products and services including Pharmacare and Spezialapotheke. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is Globomedica AG. Its competitors include Xantis Pharma, DCS Pharma and RUWAG.
Company details
Globomedica was established in 2009 and is based in Egg, Switzerland. Operations focus on the distribution of diversified pharmaceutical products within the healthcare sector. The company is led by Managing Director Peter T Vetterli. Services are facilitated through the online domain globomedica.ch, supporting logistics and supply chain needs for various drug categories in the region.
- Headquarters Egg, Switzerland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website globomedica.ch
- Acquired by The Biomedica (Mar 2016)
- Legal Name Globomedica Ag
- Investors
- Acquired byThe Biomedica
(Mar 2016)
Products & Services of Globomedica
Globomedica offers a comprehensive portfolio of products and services, including Pharmacare and Spezialapotheke.
Tailored solutions for pharmaceutical product distribution
Direct shipment of medications for special therapy areas
Investors in Globomedica
Globomedica has secured backing from 1 investor. Prominent investors backing the company include The Biomedica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
The Biomedica is engaged in publishing open access scientific journals. | thebiomedica.org | Austin, USA |
Investor details for Globomedica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Globomedica
1 people are tracked at Globomedica (1 in leadership).
| Name | Role | Group |
|---|---|---|
Peter T Vetterli | Managing Director | Leadership |
Complete people profiles for Globomedica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Globomedica
2 dated milestones of Globomedica across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Globomedica is founded.
- Exit Acquired by The Biomedica.
Competitors of Globomedica
Globomedica has 3 listed competitors in our database. They include Xantis Pharma, DCS Pharma and RUWAG.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| xantispharma.com | 2015 | Zug, Switzerland | Distributor of generic prescription and over-the-counter products | |||
| dcspharma.com | 2016 | Basel, Switzerland | Pharmaceutical products are distributed by DCS Pharma in Switzerland. | |||
| ruwag.ch | 1987 | Bettlach, Switzerland | Distributor of drugs |
Detailed competitors of Globomedica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Globomedica
Globomedica was founded in 2009.
Globomedica is headquartered in Egg, Switzerland. It is registered at Egg, Zurich, Switzerland.
Globomedica was established in 2009 and is based in Egg, Switzerland. Operations focus on the distribution of diversified pharmaceutical products within the healthcare sector. The company is led by Managing Director Peter T Vetterli. Services are facilitated through the online domain globomedica.ch, supporting logistics and supply chain needs for various drug categories in the region.
Globomedica's top competitors include DCS Pharma, RUWAG and Xantis Pharma.
Globomedica offers Pharmacare and Spezialapotheke.
Globomedica has 1 investor. Key investors include The Biomedica.
Globomedica operates through Globomedica Ag.
Yes. Globomedica was acquired by The Biomedica in March 2016.